Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPROVE-Open: EXPAREL for Pain Relief in Colectomy
NCT01507220Phase 4Terminated
- Sponsor
- Pacira BioSciences
- Start
- Mar 2012
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bupivacaine extended release liposome injection in Persistent postsurgical pain (PPSP) (2 arms), sponsored by Pacira BioSciences. Primary endpoints: Total Opioid Burden and Health Economic Benefit. Started Mar 2012; status: terminated.
02
Drugs
bupivacaine extended release liposome injection
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT01507220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01507220.